ReShape Lifesciences Inc. (RSLS) financial statements (2021 and earlier)

Company profile

Business Address 1001 CALLE AMANECER
SAN CLEMENTE, CA 92673
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments336103812
Cash and cash equivalents336103812
Restricted cash and investments     00
Receivables(1)(1)10000
Inventory, net of allowances, customer advances and progress billings2(0)13221
Inventory2(0)13221
Prepaid expense12     
Other current assets00     
Other undisclosed current assets4610010
Total current assets:91091461113
Noncurrent Assets
Inventory, Noncurrent      1
Operating lease, right-of-use asset01
Property, plant and equipment1000000
Intangible assets, net (including goodwill)14143773   
Goodwill   27   
Intangible assets, net (excluding goodwill)14143746   
Other noncurrent assets0011111
Other undisclosed noncurrent assets1315    (1)
Total noncurrent assets:28303875111
TOTAL ASSETS:3740468971214
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7867446
Accounts payable4421100
Accrued liabilities4456344
Employee-related liabilities      1
Interest and dividends payable     01
Debt422  13
Other undisclosed current liabilities10    (1)
Total current liabilities:121087448
Noncurrent Liabilities
Long-term debt and lease obligation934  1 
Long-term debt, excluding current maturities934  1 
Operating lease, liability00
Liabilities, other than long-term debt112    
Deferred tax liabilities, net2    
Deferred income tax liabilities11
Other undisclosed noncurrent liabilities11 503 
Total noncurrent liabilities:1156503 
Total liabilities:23161512488
Stockholders' equity
Stockholders' equity attributable to parent, including:14243276347
Common stock0 00001
Additional paid in capital529517451411304281258
Accumulated other comprehensive loss(0)(0)     
Accumulated deficit(515)(493)(419)(335)(301)(278)(252)
Other undisclosed stockholders' equity attributable to parent0000   
Total stockholders' equity:14243276347
TOTAL LIABILITIES AND EQUITY:3740468971214

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues11151110 
Revenue, net1   
Cost of revenue
(Cost of Goods and Services Sold)
(5)(6)(0)(1)(0)(0) 
Gross profit:690000 
Operating expenses(19)(34)(39)(32)(23)(28)(26)
Operating loss:(12)(24)(39)(31)(23)(28)(26)
Nonoperating income (expense)0(1)(0)000(0)
Investment income, nonoperating   0000
Foreign currency transaction gain, before tax00     
Other nonoperating income (expense) (1)(0)(0)00(0)
Interest and debt expense(8)(0) (0)(4)(0)(1)
Loss from continuing operations before equity method investments, income taxes:(20)(26)(39)(31)(27)(28)(26)
Other undisclosed loss from continuing operations before income taxes(2)(49)(0)(5)   
Loss from continuing operations before income taxes:(22)(75)(39)(36)(27)(28)(26)
Income tax benefit0132   
Loss from continuing operations:(22)(74)(35)(34)(27)(28)(26)
Loss from discontinued operations  (46)    
Net loss:(22)(74)(81)(34)(27)(28)(26)
Other undisclosed net income attributable to parent    42 
Net loss attributable to parent:(22)(74)(81)(34)(23)(25)(26)
Other undisclosed net loss available to common stockholders, basic  (3)    
Net loss available to common stockholders, diluted:(22)(74)(84)(34)(23)(25)(26)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(22)(74)(81)(34)(27)(28)(26)
Comprehensive loss:(22)(74)(81)(34)(27)(28)(26)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)   2 
Comprehensive loss, net of tax, attributable to parent:(22)(74)(81)(34)(27)(25)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: